Skip to content
    Professional Development

    Evaluation Frameworks in Pediatric Oncology Physician Education Across LMICs

    Berg et alPediatric blood & cancer

    Evaluation Frameworks in Pediatric Oncology Physician Education Across LMICs
    In low- and middle-income countries (LMICs), pediatric oncology survival lags behind high-income settings, underscoring the necessity of structured physician training to build clinical workforce capacity. A PRISMA-ScR–compliant scoping review across PubMed, PsycINFO, Web of Science, and ERIC identified peer-reviewed literature published between January 1, 2005, and May 31, 2026, to map pediatric oncology physician education interventions and their evaluation frameworks.
    Out of 10,580 unique records screened, 27 studies met the inclusion criteria. The majority of identified programs focused on continuing education for practicing clinicians and incorporated online learning modalities. However, structured evaluation models or theoretical frameworks were infrequently used, appearing in only 18.5% (n = 5) of interventions.
    Evaluation reporting varied significantly across assessment tiers: reach-level data (such as enrollment numbers) were documented in 100% (n = 27) of studies, reaction-level evaluations in 74.1% (n = 20), learning-level evaluations in 66.7% (n = 18), and broader outcomes-level evaluations in 70.4% (n = 19). Assessments capturing higher-level clinical practice impacts, such as patient care delivery and institutional outcomes, remain sparse, demonstrating a need for standardized, continuum-based evaluation frameworks to measure the tangible impact of oncology workforce development in resource-limited environments.

    Key Takeaways

    • Across 27 pediatric oncology educational interventions identified in LMICs, formal educational evaluation frameworks or theoretical models were incorporated in only 18.5% (n = 5) of studies.
    • While participant reach metrics were documented by 100% (n = 27) of studies, reaction-level assessments were reported in 74.1% (n = 20), learning-level in 66.7% (n = 18), and outcomes-level in 70.4% (n = 19), with higher-level patient care and institutional metrics rarely evaluated.
    Read the original sourcePediatric blood & cancer